AIVL has released a new report, looking at the needs of people living with Hepatitis C after leaving custodial settings in Australia. The report contains a series of recommendations aimed at addressing the spread of blood borne viruses (BBVs) in the Australian community more broadly, including trialling of a Needle and Syringe Program (NSP) in prison and increased focus on transitional arrangements for people returning to the community.Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Curative treatment uptake for chronic hepatitis C (CHC) is generally at its lowest in local areas where prevalence of the virus is at its highest, according to the inaugural Hepatitis C Mapping Project National Report 2016 recently launched in Melbourne.Read More
Hundreds of thousands of Australians with hepatitis C are failing to access new curative drugs, despite the Government subsidising them at huge cost to the taxpayer.
The trend means the Government is at risk of missing its target to eradicate hepatitis C and of spending far more than necessary on the treatments.Read More
Australia will not achieve the goal of eradicating hepatitis C without further action to ensure patients are identified and treated.
Speaking with PharmaDispatch following her appointment as president of Hepatitis Australia, Felicity McNeill PSM, said so much positive work has been done, with thousands of people cured, but all stakeholders must come together to address the fact treatment rates are in decline.Read More